Sunshine Biopharma Inc. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
Sunshine Biopharma Inc. (SBFM) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2021-03-30
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2020-12-31 was $0.00.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2020 was $0.00.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2019 was -$2.11K.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, operating income (loss) for fiscal 2018 was -$8.85K.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month as first filed | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 6 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | -$3.52K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | -$3.52K derived: sum of 3 quarters · filed 2021-03-30 | -$2.11K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | -$3.52K derived: sum of 2 quarters · filed 2021-03-30 | -$2.11K derived: sum of 3 quarters · filed 2021-03-30 | -$706.00 derived: sum of 4 quarters · filed 2021-03-30 | |
| 2019-12-31 | -$3.52K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$2.11K derived: sum of 2 quarters · filed 2021-03-30 | -$706.00 derived: sum of 3 quarters · filed 2021-03-30 | -$2.11K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.41K 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2019-11-13 | $2.81K derived: sum of 2 quarters · filed 2020-11-12 | $1.41K 10-Q · filed 2020-11-12 | -$7.81K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $1.41K 10-Q/A · filed 2020-08-31 | $0.00 10-Q · filed 2019-08-15 | $1.41K 10-Q/A · filed 2020-08-31 | -$9.21K derived: sum of 3 quarters · filed 2020-08-31 | -$141.00 derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $1.41K 10-Q · filed 2020-05-18 | -$10.62K derived: sum of 2 quarters · filed 2020-05-18 | -$1.55K derived: sum of 3 quarters · filed 2020-05-18 | $8.01K derived: sum of 4 quarters · filed 2020-05-18 | |
| 2018-12-31 | -$12.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | -$2.95K derived: sum of 2 quarters · filed 2020-05-01 | $6.61K derived: sum of 3 quarters · filed 2020-05-01 | -$8.85K 10-K · filed 2020-05-01 | |
| 2018-09-30 | $9.07K 10-Q · filed 2019-11-13 | $18.63K derived: sum of 2 quarters · filed 2019-11-13 | $3.18K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $9.56K 10-Q · filed 2019-08-15 | -$5.89K 10-Q · filed 2019-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |